X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CELLULAR ONCOLOGY

期刊標題檢索 CELL ONCOL 最新評論: Submitted in early April, accepted at the end of October, with 2 mont... (2023-10-31)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CELLULAR ONCOLOGY]您好,您是該頁面的第 35743 位訪客。

期刊簡介
期刊名稱CELLULAR ONCOLOGY CELLULAR ONCOLOGY
LetPub Score
7.3
50 ratings
Rate

Reputation
8.6

Influence
6.3

Speed
7.0

期刊簡稱CELL ONCOL
ISSN2211-3428
E-ISSN2211-3436
h-index31
CiteScore
CiteScoreSJRSNIPCiteScore Rank
10.301.4891.031
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Oncology
Q156 / 404
Category: Medicine
Subcategory: Molecular Medicine
Q132 / 178
Category: Medicine
Subcategory: Cancer Research
Q148 / 230

自引率 (2023-2024)2.00%自引率趨勢
掲載範囲
The Official Journal of the International Society for Cellular Oncology
Focuses on translational research
Addresses the conversion of cell biology to clinical applications
Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.
In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.
官方網站https://www.springer.com/13402
在線稿件提交https://www.editorialmanager.com/ceon
開放訪問No
出版商Springer Netherlands
主題領域ONCOLOGY
出版國/地區NETHERLANDS
發行頻率年6回刊行
創刊年2011
每年文章數136每年文章數趨勢
黃金OA百分比29.94%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ267/205
ONCOLOGYSCIEQ168/322
PATHOLOGYSCIEQ111/88
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2211-3428%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 12 Month(s)
競爭力 *來自作者的數據: About 25%
參考鏈接
相關期刊 【CELLULAR ONCOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal of Extracellular VesiclesH-index: 0

    CiteScore: 27.30
    AGING CELLH-index: 113

    CiteScore: 14.40
    Science SignalingH-index: 128

    CiteScore: 9.50
    Cell Death DiscoveryH-index: 0

    CiteScore: 8.30
    Stem Cell ReportsH-index: 55

    CiteScore: 10.50
    Frontiers in Cell and Developmental BiologyH-index: 0

    CiteScore: 9.70
    Stem Cell Reviews and ReportsH-index: 61

    CiteScore: 9.30
    Cell RegenerationH-index: 0

    CiteScore: 5.80
    Cell Adhesion & MigrationH-index: 0

    CiteScore: 6.40
    Analytical Cellular PathologyH-index: 18

    CiteScore: 4.90
    學科內最受檢索的期刊 頁面查看次數
    Oncotarget633967
    Frontiers in Cell and Developmental Biology202345
    Cell Death Discovery107020
    Stem Cell Reports81277
    Science Signaling65700
    Journal of Extracellular Vesicles44107
    Current Stem Cell Research & Therapy35004
    AGING CELL33549
    Stem Cell Reviews and Reports31738
    Analytical Cellular Pathology26466
  •  

    CELLULAR ONCOLOGY CELLULAR ONCOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)
  [CELLULAR ONCOLOGY] 的評論撰寫評論
作者: 北陆安平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-31 21:46:04 評論於
Submitted in early April, accepted at the end of October, with 2 months of experiments in between
(0) 讚! | 北陆安平

作者: 北陆安平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-31 16:24:55 評論於
It's pretty fast for you. It took around 7 months for me to get accepted
(0) 讚! | 北陆安平

作者: 北马美美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 22:08:37 評論於
What's your problem?
(0) 讚! | 北马美美

作者: 北马美美


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-29 12:02:19 評論於
Wow, it's been such a long time?
(0) 讚! | 北马美美

作者: Phoebe


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-10-09 23:53:27 評論於
Have you heard any news? Another magazine asked me to switch to them, I'm afraid
(0) 讚! | Phoebe

作者: 无影白曼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-08-13 17:58:41 評論於
Research focus: Tumors; experience sharing: After a previous journal rejection, the publisher recommended this journal. I found out that earlier this year they had accepted a review article similar to ours on another type of cancer. But unfortunately, our submission was rejected without any reason
(0) 讚! | 无影白曼

作者: 混元新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-07-18 21:53:39 評論於
Don't you have invited reviewers? It will be like this, waiting all the time
(0) 讚! | 混元新曦

作者: Alger Croft


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-26 19:13:46 評論於
Has anyone applied recently? It's been six months and still under review
(0) 讚! | Alger Croft

作者: Alger Croft


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-26 08:28:59 評論於
You are really fast. I submitted my application one month after you did, and it's still under review
(0) 讚! | Alger Croft

作者: Alger Croft


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-24 09:49:21 評論於
Heavy research emphasis: tumor experience sharing: has anyone submitted recently? It's been under review for 5 months. Oh my god
(0) 讚! | Alger Croft

作者: Alger Croft


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-06-23 23:19:59 評論於
Review speed: 4.0
Research focus: tumor
Experience sharing: Has anyone submitted recently? Mine has been under review for almost half a year
(0) 讚! | Alger Croft

作者: 长拳瑞灵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-03-28 10:03:15 評論於
Who said this magazine is fast~~~Submitted on 2022.10.30, 15 reviewers accepted by 2022.11.25 (scared the pee out of me) First review came back on 2023.1.4 (total of two reviewers), revised on 2023.1.16, one reviewer's opinion received on 2023.2.6, accepted on 2023.3.29
(0) 讚! | 长拳瑞灵

作者: 璃月妍妍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-12-02 11:08:21 評論於
Can you disclose which magazine you switched to?
(0) 讚! | 璃月妍妍

作者: 四风晨朗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-11-13 08:01:46 評論於
How long does the whole process take?
(0) 讚! | 四风晨朗

作者: 坠星蕙若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-10-26 08:14:25 評論於
Review speed: 6.0 | Submission success rate: 25.0
Experience sharing: None
(0) 讚! | 坠星蕙若

作者: Allen Galsworthy


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-08-10 16:15:04 評論於
Review speed: 3.0 | Submission acceptance rate: 25.0
Experience sharing: The review speed is acceptable, but the journal has high requirements. There were five reviewers in the first round, four passed, but one reviewer had very strict requirements. The manuscript was rejected after the second round of review, which is disappointing
(0) 讚! | Allen Galsworthy

作者: Gemma Stevenson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-27 23:19:39 評論於
The review is fast, and the editor-in-chief is very responsible
(0) 讚! | Gemma Stevenson

作者: 南风乙酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-26 15:22:59 評論於
Go ahead and give it a try. If you're in a hurry to graduate, don't worry about it. I switched to another magazine last month and now have an editor who has already reviewed my manuscript
(0) 讚! | 南风乙酉

作者: 伏象庚子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-06-21 09:48:26 評論於
Don't scare me, it's been half a year and I still haven't found a reviewer? Is the editor Chinese? Are there any successful submission cases? How long does it take?
(0) 讚! | 伏象庚子

作者: 南风乙酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-07 17:49:50 評論於
You messed up, it's not super good, it's super slow. It's been over half a year and still on assign
(0) 讚! | 南风乙酉

作者: 南风乙酉


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-05-07 12:42:36 評論於
So slow, my goodness, how many days has it been, I regret subscribing to this magazine
(0) 讚! | 南风乙酉

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 21:12:09 評論於
Emphasis should be placed on including as much preliminary research work as possible, with no limit on the number of papers
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:21:28 評論於
Before conducting your research, it is necessary to conduct a comprehensive literature search and read relevant review articles in the field
(0) 讚! | 维尔娜菲茨杰拉德

作者: Darlene Pepys


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 17:05:43 評論於
How to comprehensively include important research in the introduction of a field?
(0) 讚! | Darlene Pepys

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 15:07:34 評論於
How many references are generally cited in an introduction?
(0) 讚! | 八坂篷蔚

首頁    上一頁    1    2    3    下一頁    末頁  (頁
/3)

開始撰寫 [CELLULAR ONCOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*